StreetInsider.com News Articles

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

Tue, 01 Sep 2026 16:01:00 -0400

SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will participate in the following September investor conferences.

Wells Fargo Healthcare Conference

1x1 Investor Meetings: Wednesday, September 9, 2026
Location: Boston

Cantor Global Healthcare Conference

Fireside Chat: Friday, September 11, 2026, 8:35 a.m. ET
1x1 Investor Meetings: Thursday, September 10, 2026
Location: New York

To access the live and archived webcast from the Cantor

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

Tue, 01 Sep 2026 16:01:00 -0400

Wells Fargo Healthcare Conference

1x1 Investor Meetings: Wednesday, September 9, 2026
Location: Boston

Cantor Global Healthcare Conference

Fireside Chat: Friday, September 11, 2026, 8:35 a.m. ET
1x1 Investor Meetings: Thursday, September 10, 2026
Location: New York

To access the live and archived webcast from the Cantor

Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975959.html

Form 144 ARS Pharmaceuticals, Filed by: Lowenthal Richard E

Tue, 25 Aug 2026 19:03:00 -0400

si-local-file:///var/storage/secattach/20260825/26975959.html

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar

Tue, 25 Aug 2026 09:08:09 -0400

PHILADELPHIA, Aug. 25, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award